Rigel Pharmaceuticals (RIGL) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.50% |
| Dec 31, 2025 | 36.00% |
| Sep 30, 2025 | 14.53% |
| Jun 30, 2025 | 8.41% |
| Mar 31, 2025 | 4.18% |
| Dec 31, 2024 | 2.13% |
| Sep 30, 2024 | -2.23% |
| Jun 30, 2024 | -3.84% |
| Mar 31, 2024 | -6.04% |
| Dec 31, 2023 | -3.37% |
| Sep 30, 2023 | -1.31% |
| Jun 30, 2023 | -3.68% |
| Mar 31, 2023 | 4.58% |
| Dec 31, 2022 | 2.43% |
| Sep 30, 2022 | 10.16% |
| Jun 30, 2022 | 8.41% |
| Mar 31, 2022 | 8.03% |
| Dec 31, 2021 | 16.45% |
| Sep 30, 2021 | 16.04% |
| Jun 30, 2021 | 15.21% |
| Mar 31, 2021 | 14.81% |
| Dec 31, 2020 | -3.48% |
| Sep 30, 2020 | -2.43% |
| Jun 30, 2020 | -1.43% |
| Mar 31, 2020 | -2.85% |
| Dec 31, 2019 | -0.87% |
| Sep 30, 2019 | -0.89% |
| Jun 30, 2019 | -3.06% |
| Mar 31, 2019 | -3.20% |
| Dec 31, 2018 | -9.25% |
| Sep 30, 2018 | -12.46% |
| Jun 30, 2018 | -11.61% |
| Mar 31, 2018 | -18.97% |
| Dec 31, 2017 | -17.41% |
| Sep 30, 2017 | -18.18% |
| Jun 30, 2017 | -16.80% |
| Mar 31, 2017 | -15.41% |
| Dec 31, 2016 | -21.20% |
| Sep 30, 2016 | -20.31% |
| Jun 30, 2016 | -19.28% |
| Dec 31, 2015 | -6.73% |